We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$688M
AUM Growth
+$59.1M
Cap. Flow
+$2.64M
Cap. Flow %
0.38%
Top 10 Hldgs %
65.8%
Holding
28
New
2
Increased
16
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$15.3M
2
ABT icon
Abbott
ABT
+$9.9M
3
GILD icon
Gilead Sciences
GILD
+$6.65M
4
BMY icon
Bristol-Myers Squibb
BMY
+$5.82M
5
THC icon
Tenet Healthcare
THC
+$5.64M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$29.2M
2
LLY icon
Eli Lilly
LLY
+$15.2M
3
MASI
Masimo
MASI
+$5.21M
4
ELV icon
Elevance Health
ELV
+$4.53M
5
UTHR icon
United Therapeutics
UTHR
+$3.92M

Sector Composition

Rank Sector Weight
1 Healthcare 98.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
$4.9M 0.71%
+40,300
New +$4.69M
UTHR icon
27
United Therapeutics
UTHR
$26.4B
– –
-28,974
Closed -$3.92M
VRTX icon
28
Vertex Pharmaceuticals
VRTX
$120B
– –
-267,050
Closed -$29.2M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2017 Portfolio in Review

As of Q2 2017, Sector Gamma AS held 28 positions worth $688M, up 9.4% from $629M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sector Gamma AS's Q2 2017 filing shows 2 new, 16 increased, 6 reduced and 2 closed positions. Its largest new stake was Biogen: 57,800 shares worth $15.7M. The largest sale was Vertex Pharmaceuticals, an estimated $29.2M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.

  • Sector Gamma AS's largest Q2 2017 buy was Biogen: 57,800 shares worth $15.7M.
  • Sector Gamma AS added most to Abbott in Q2 2017, an estimated $9.9M increase.
  • Sector Gamma AS's biggest Q2 2017 reduction was Eli Lilly, cutting an estimated $15.2M.
  • Sector Gamma AS fully exited Vertex Pharmaceuticals in Q2 2017, selling an estimated $29.2M.
  • Sector Gamma AS's ten largest holdings make up 66% of its $688M portfolio in Q2 2017.
  • Sector Gamma AS opened 2 new positions and closed 2 in Q2 2017.
  • Sector Gamma AS's portfolio value rose 9.4% quarter-over-quarter to $688M.

Based on Sector Gamma AS's 13F filing for Q2 2017, filed 14 Aug 2017.